Friday, July 20, 6:24 AM
Alnylam Pharmaceuticals (ALNY) is in discussions with "more than one" potential partner to help it carry out Phase II and Phase III studies of its ALN-PCS treatment for high cholestoral, CEO John Maraganore says, although he declines to name names.
From Seeking Alpha.
- Forums
- ASX - By Stock
- BLT
- alnylam positive clinical results (headline on
alnylam positive clinical results (headline on, page-23
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)